Search All News
Natasha Kulviwat, a rising high school senior, discovered a protein that may serve as predictor for suicide and could potentially lead to new strategies for intervention and prevention.
Opening remarks were delivered by Dr. Blair Simpson, interim chair of psychiatry at Columbia.
Source:Philly VoiceDecember 5, 2019
"In our participants, ketamine appears to have increased resilience and reduced demoralization after a lapse," Dr. Elias Dakwar said.
- December 2, 2019
People with opioid addiction face a high risk of overdose after ending treatment, even when treated for 18 months, a Columbia study has found.
Source:Phys.orgNovember 13, 2019
Dr. Jonathan Javitch distills research that reveals the mechanics of how some transporter proteins function with stunning specificity.
- November 8, 2019
Dr. J. John Mann of Columbia University breaks down some of the key takeaways of this paper regarding the relationship between 922 prescription drugs and 43,978 suicidal events.
Source:MedscapeNovember 4, 2019
"Overall, we found that 2.6% of kids with a new diagnosis of ADHD were treated with an antipsychotic medication despite no FDA indication," study investigator Dr. Ryan S. Sultan.
Source:PoliticoOctober 28, 2019
In a recent JAMA Viewpoint, Drs. Myrna Weissman and Ardesheer Talati argued that clinicians should still enter information about patients' personal life events into EHRs.
Source:Self MagazineOctober 25, 2019
“FTD basically peaks in middle age,” Edward D. Huey says, “as opposed to Alzheimer’s, where your chances of getting it go up as you get older.”
- August 28, 2019
Dr. Gary Brucato, the Center of Prevention and Evaluation's Assistant Director, breaks down some of the early warning signs and symptoms of possible emergent psychotic illness.
Source:scienceAugust 21, 2019
"It's not a fact-finding mission, like we're kind of blindly throwing a spear," Dr. Randy Auerbach says. Instead, MAPS relies on established theories and data on suicidal behavior.